Sustained Remission With Mogamulizumab in Peripheral T Cell Lymphoma With Aberrant CD20 Expression: Case Report and Literature Review
Journal of Cancer Therapy
doi 10.4236/jct.2018.93018
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
Scientific Research Publishing, Inc.